- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-octamer
- Ligands
- 56 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 48 x ACT: ACETATE ION(Non-functional Binders)
ACT.7: 8 residues within 4Å:- Chain A: I.19, E.29, R.41, A.42, A.43, E.376, D.377
- Chain E: R.411
Ligand excluded by PLIPACT.8: 5 residues within 4Å:- Chain A: F.255, D.257, G.258, D.296, D.297
Ligand excluded by PLIPACT.9: 1 residues within 4Å:- Chain A: D.354
Ligand excluded by PLIPACT.10: 6 residues within 4Å:- Chain A: I.10, I.11, E.12, I.35, I.86, G.87
Ligand excluded by PLIPACT.11: 3 residues within 4Å:- Chain A: F.137, Q.408, A.415
Ligand excluded by PLIPACT.12: 4 residues within 4Å:- Chain A: G.240, P.285, V.287
- Ligands: EDO.5
Ligand excluded by PLIPACT.22: 8 residues within 4Å:- Chain B: I.19, E.29, R.41, A.42, A.43, E.376, D.377
- Chain F: R.411
Ligand excluded by PLIPACT.23: 5 residues within 4Å:- Chain B: F.255, D.257, G.258, D.296, D.297
Ligand excluded by PLIPACT.24: 1 residues within 4Å:- Chain B: D.354
Ligand excluded by PLIPACT.25: 6 residues within 4Å:- Chain B: I.10, I.11, E.12, I.35, I.86, G.87
Ligand excluded by PLIPACT.26: 3 residues within 4Å:- Chain B: F.137, Q.408, A.415
Ligand excluded by PLIPACT.27: 4 residues within 4Å:- Chain B: G.240, P.285, V.287
- Ligands: EDO.20
Ligand excluded by PLIPACT.37: 8 residues within 4Å:- Chain C: I.19, E.29, R.41, A.42, A.43, E.376, D.377
- Chain H: R.411
Ligand excluded by PLIPACT.38: 5 residues within 4Å:- Chain C: F.255, D.257, G.258, D.296, D.297
Ligand excluded by PLIPACT.39: 1 residues within 4Å:- Chain C: D.354
Ligand excluded by PLIPACT.40: 6 residues within 4Å:- Chain C: I.10, I.11, E.12, I.35, I.86, G.87
Ligand excluded by PLIPACT.41: 3 residues within 4Å:- Chain C: F.137, Q.408, A.415
Ligand excluded by PLIPACT.42: 4 residues within 4Å:- Chain C: G.240, P.285, V.287
- Ligands: EDO.35
Ligand excluded by PLIPACT.52: 8 residues within 4Å:- Chain D: I.19, E.29, R.41, A.42, A.43, E.376, D.377
- Chain G: R.411
Ligand excluded by PLIPACT.53: 5 residues within 4Å:- Chain D: F.255, D.257, G.258, D.296, D.297
Ligand excluded by PLIPACT.54: 1 residues within 4Å:- Chain D: D.354
Ligand excluded by PLIPACT.55: 6 residues within 4Å:- Chain D: I.10, I.11, E.12, I.35, I.86, G.87
Ligand excluded by PLIPACT.56: 3 residues within 4Å:- Chain D: F.137, Q.408, A.415
Ligand excluded by PLIPACT.57: 4 residues within 4Å:- Chain D: G.240, P.285, V.287
- Ligands: EDO.50
Ligand excluded by PLIPACT.67: 8 residues within 4Å:- Chain A: R.411
- Chain E: I.19, E.29, R.41, A.42, A.43, E.376, D.377
Ligand excluded by PLIPACT.68: 5 residues within 4Å:- Chain E: F.255, D.257, G.258, D.296, D.297
Ligand excluded by PLIPACT.69: 1 residues within 4Å:- Chain E: D.354
Ligand excluded by PLIPACT.70: 6 residues within 4Å:- Chain E: I.10, I.11, E.12, I.35, I.86, G.87
Ligand excluded by PLIPACT.71: 3 residues within 4Å:- Chain E: F.137, Q.408, A.415
Ligand excluded by PLIPACT.72: 4 residues within 4Å:- Chain E: G.240, P.285, V.287
- Ligands: EDO.65
Ligand excluded by PLIPACT.82: 8 residues within 4Å:- Chain B: R.411
- Chain F: I.19, E.29, R.41, A.42, A.43, E.376, D.377
Ligand excluded by PLIPACT.83: 5 residues within 4Å:- Chain F: F.255, D.257, G.258, D.296, D.297
Ligand excluded by PLIPACT.84: 1 residues within 4Å:- Chain F: D.354
Ligand excluded by PLIPACT.85: 6 residues within 4Å:- Chain F: I.10, I.11, E.12, I.35, I.86, G.87
Ligand excluded by PLIPACT.86: 3 residues within 4Å:- Chain F: F.137, Q.408, A.415
Ligand excluded by PLIPACT.87: 4 residues within 4Å:- Chain F: G.240, P.285, V.287
- Ligands: EDO.80
Ligand excluded by PLIPACT.97: 8 residues within 4Å:- Chain D: R.411
- Chain G: I.19, E.29, R.41, A.42, A.43, E.376, D.377
Ligand excluded by PLIPACT.98: 5 residues within 4Å:- Chain G: F.255, D.257, G.258, D.296, D.297
Ligand excluded by PLIPACT.99: 1 residues within 4Å:- Chain G: D.354
Ligand excluded by PLIPACT.100: 6 residues within 4Å:- Chain G: I.10, I.11, E.12, I.35, I.86, G.87
Ligand excluded by PLIPACT.101: 3 residues within 4Å:- Chain G: F.137, Q.408, A.415
Ligand excluded by PLIPACT.102: 4 residues within 4Å:- Chain G: G.240, P.285, V.287
- Ligands: EDO.95
Ligand excluded by PLIPACT.112: 8 residues within 4Å:- Chain C: R.411
- Chain H: I.19, E.29, R.41, A.42, A.43, E.376, D.377
Ligand excluded by PLIPACT.113: 5 residues within 4Å:- Chain H: F.255, D.257, G.258, D.296, D.297
Ligand excluded by PLIPACT.114: 1 residues within 4Å:- Chain H: D.354
Ligand excluded by PLIPACT.115: 6 residues within 4Å:- Chain H: I.10, I.11, E.12, I.35, I.86, G.87
Ligand excluded by PLIPACT.116: 3 residues within 4Å:- Chain H: F.137, Q.408, A.415
Ligand excluded by PLIPACT.117: 4 residues within 4Å:- Chain H: G.240, P.285, V.287
- Ligands: EDO.110
Ligand excluded by PLIP- 8 x MG: MAGNESIUM ION(Non-covalent)
MG.13: 7 residues within 4Å:- Chain A: Q.169, D.248, E.290, D.317, K.342, K.393
- Ligands: 2PG.14
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.248, A:E.290, A:D.317, H2O.3, H2O.4
MG.28: 7 residues within 4Å:- Chain B: Q.169, D.248, E.290, D.317, K.342, K.393
- Ligands: 2PG.29
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.248, B:E.290, B:D.317, H2O.9, H2O.11
MG.43: 7 residues within 4Å:- Chain C: Q.169, D.248, E.290, D.317, K.342, K.393
- Ligands: 2PG.44
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.248, C:E.290, C:D.317, H2O.16, H2O.18
MG.58: 7 residues within 4Å:- Chain D: Q.169, D.248, E.290, D.317, K.342, K.393
- Ligands: 2PG.59
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.248, D:E.290, D:D.317, H2O.23, H2O.25
MG.73: 7 residues within 4Å:- Chain E: Q.169, D.248, E.290, D.317, K.342, K.393
- Ligands: 2PG.74
5 PLIP interactions:3 interactions with chain E, 2 Ligand-Water interactions- Metal complexes: E:D.248, E:E.290, E:D.317, H2O.30, H2O.31
MG.88: 7 residues within 4Å:- Chain F: Q.169, D.248, E.290, D.317, K.342, K.393
- Ligands: 2PG.89
5 PLIP interactions:3 interactions with chain F, 2 Ligand-Water interactions- Metal complexes: F:D.248, F:E.290, F:D.317, H2O.36, H2O.38
MG.103: 7 residues within 4Å:- Chain G: Q.169, D.248, E.290, D.317, K.342, K.393
- Ligands: 2PG.104
5 PLIP interactions:3 interactions with chain G, 2 Ligand-Water interactions- Metal complexes: G:D.248, G:E.290, G:D.317, H2O.43, H2O.45
MG.118: 7 residues within 4Å:- Chain H: Q.169, D.248, E.290, D.317, K.342, K.393
- Ligands: 2PG.119
5 PLIP interactions:3 interactions with chain H, 2 Ligand-Water interactions- Metal complexes: H:D.248, H:E.290, H:D.317, H2O.50, H2O.52
- 8 x 2PG: 2-PHOSPHOGLYCERIC ACID(Non-covalent)
2PG.14: 17 residues within 4Å:- Chain A: G.47, A.48, S.49, T.50, E.54, H.161, Q.169, E.170, D.248, A.250, D.317, D.318, K.342, Q.345, R.371, S.372
- Ligands: MG.13
19 PLIP interactions:19 interactions with chain A- Hydrogen bonds: A:A.48, A:S.49, A:S.49, A:S.49, A:Q.169, A:E.170, A:D.318, A:K.342, A:Q.345, A:S.372
- Water bridges: A:E.211, A:E.290, A:D.291, A:D.291, A:K.393
- Salt bridges: A:H.161, A:K.342, A:K.342, A:R.371
2PG.29: 17 residues within 4Å:- Chain B: G.47, A.48, S.49, T.50, E.54, H.161, Q.169, E.170, D.248, A.250, D.317, D.318, K.342, Q.345, R.371, S.372
- Ligands: MG.28
19 PLIP interactions:19 interactions with chain B- Hydrogen bonds: B:A.48, B:S.49, B:S.49, B:S.49, B:Q.169, B:E.170, B:D.318, B:K.342, B:Q.345, B:S.372
- Water bridges: B:E.211, B:E.290, B:D.291, B:D.291, B:K.393
- Salt bridges: B:H.161, B:K.342, B:K.342, B:R.371
2PG.44: 17 residues within 4Å:- Chain C: G.47, A.48, S.49, T.50, E.54, H.161, Q.169, E.170, D.248, A.250, D.317, D.318, K.342, Q.345, R.371, S.372
- Ligands: MG.43
19 PLIP interactions:19 interactions with chain C- Hydrogen bonds: C:A.48, C:S.49, C:S.49, C:S.49, C:Q.169, C:E.170, C:D.318, C:K.342, C:Q.345, C:S.372
- Water bridges: C:E.211, C:E.290, C:D.291, C:D.291, C:K.393
- Salt bridges: C:H.161, C:K.342, C:K.342, C:R.371
2PG.59: 17 residues within 4Å:- Chain D: G.47, A.48, S.49, T.50, E.54, H.161, Q.169, E.170, D.248, A.250, D.317, D.318, K.342, Q.345, R.371, S.372
- Ligands: MG.58
19 PLIP interactions:19 interactions with chain D- Hydrogen bonds: D:A.48, D:S.49, D:S.49, D:S.49, D:Q.169, D:E.170, D:D.318, D:K.342, D:Q.345, D:S.372
- Water bridges: D:E.211, D:E.290, D:D.291, D:D.291, D:K.393
- Salt bridges: D:H.161, D:K.342, D:K.342, D:R.371
2PG.74: 17 residues within 4Å:- Chain E: G.47, A.48, S.49, T.50, E.54, H.161, Q.169, E.170, D.248, A.250, D.317, D.318, K.342, Q.345, R.371, S.372
- Ligands: MG.73
17 PLIP interactions:17 interactions with chain E- Hydrogen bonds: E:A.48, E:S.49, E:S.49, E:S.49, E:Q.169, E:D.318, E:K.342, E:Q.345, E:R.371, E:S.372
- Water bridges: E:E.211, E:D.318, E:K.393
- Salt bridges: E:H.161, E:K.342, E:K.342, E:R.371
2PG.89: 17 residues within 4Å:- Chain F: G.47, A.48, S.49, T.50, E.54, H.161, Q.169, E.170, D.248, A.250, D.317, D.318, K.342, Q.345, R.371, S.372
- Ligands: MG.88
17 PLIP interactions:17 interactions with chain F- Hydrogen bonds: F:A.48, F:S.49, F:S.49, F:S.49, F:Q.169, F:D.318, F:K.342, F:Q.345, F:R.371, F:S.372
- Water bridges: F:E.211, F:D.318, F:K.393
- Salt bridges: F:H.161, F:K.342, F:K.342, F:R.371
2PG.104: 17 residues within 4Å:- Chain G: G.47, A.48, S.49, T.50, E.54, H.161, Q.169, E.170, D.248, A.250, D.317, D.318, K.342, Q.345, R.371, S.372
- Ligands: MG.103
17 PLIP interactions:17 interactions with chain G- Hydrogen bonds: G:A.48, G:S.49, G:S.49, G:S.49, G:Q.169, G:D.318, G:K.342, G:Q.345, G:R.371, G:S.372
- Water bridges: G:E.211, G:D.318, G:K.393
- Salt bridges: G:H.161, G:K.342, G:K.342, G:R.371
2PG.119: 17 residues within 4Å:- Chain H: G.47, A.48, S.49, T.50, E.54, H.161, Q.169, E.170, D.248, A.250, D.317, D.318, K.342, Q.345, R.371, S.372
- Ligands: MG.118
19 PLIP interactions:19 interactions with chain H- Hydrogen bonds: H:A.48, H:S.49, H:S.49, H:S.49, H:Q.169, H:D.318, H:K.342, H:Q.345, H:R.371, H:S.372
- Water bridges: H:E.211, H:D.317, H:D.317, H:D.318, H:K.393
- Salt bridges: H:H.161, H:K.342, H:K.342, H:R.371
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ahmad, M. et al., Structural snapshots of Mycobacterium tuberculosis enolase reveal dual mode of 2PG binding and its implication in enzyme catalysis. Iucrj (2023)
- Release Date
- 2022-01-26
- Peptides
- Enolase: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-octamer
- Ligands
- 56 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 48 x ACT: ACETATE ION(Non-functional Binders)
- 8 x MG: MAGNESIUM ION(Non-covalent)
- 8 x 2PG: 2-PHOSPHOGLYCERIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ahmad, M. et al., Structural snapshots of Mycobacterium tuberculosis enolase reveal dual mode of 2PG binding and its implication in enzyme catalysis. Iucrj (2023)
- Release Date
- 2022-01-26
- Peptides
- Enolase: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
AG
AH
A